Brokers Set Expectations for Spectral AI, Inc.’s FY2027 Earnings (NASDAQ:MDAI)

Spectral AI, Inc. (NASDAQ:MDAI) – Analysts at HC Wainwright issued their FY2027 EPS estimates for shares of Spectral AI in a research report issued on Tuesday, August 13th. HC Wainwright analyst S. Ramakanth expects that the company will post earnings of $0.53 per share for the year. HC Wainwright currently has a “Buy” rating and a $3.50 target price on the stock. The consensus estimate for Spectral AI’s current full-year earnings is ($0.62) per share. HC Wainwright also issued estimates for Spectral AI’s FY2028 earnings at $0.37 EPS.

A number of other analysts have also recently weighed in on the company. Northland Capmk raised Spectral AI to a “strong-buy” rating in a research report on Monday. Northland Securities began coverage on Spectral AI in a research note on Monday. They set an “outperform” rating and a $6.00 price target for the company.

Spectral AI Price Performance

NASDAQ MDAI opened at $1.65 on Wednesday. The business’s 50-day moving average price is $1.71 and its 200 day moving average price is $1.89. Spectral AI has a 52-week low of $1.32 and a 52-week high of $19.50.

Spectral AI (NASDAQ:MDAI) last posted its quarterly earnings data on Monday, August 12th. The company reported ($0.16) EPS for the quarter, missing analysts’ consensus estimates of ($0.14) by ($0.02). The business had revenue of $7.48 million for the quarter, compared to the consensus estimate of $6.00 million.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently made changes to their positions in MDAI. Cantor Fitzgerald L. P. acquired a new stake in Spectral AI in the fourth quarter valued at about $38,000. Virtu Financial LLC purchased a new position in shares of Spectral AI during the 1st quarter worth approximately $38,000. Forum Financial Management LP purchased a new position in shares of Spectral AI during the 2nd quarter worth approximately $51,000. Murchinson Ltd. acquired a new stake in shares of Spectral AI in the 1st quarter valued at approximately $85,000. Finally, Highlander Partners L.P. boosted its stake in shares of Spectral AI by 18.6% in the fourth quarter. Highlander Partners L.P. now owns 900,000 shares of the company’s stock valued at $2,214,000 after buying an additional 141,416 shares in the last quarter. 67.08% of the stock is currently owned by institutional investors and hedge funds.

About Spectral AI

Spectral AI, Inc, an artificial intelligence (AI) company, focuses on developing predictive medical diagnostics in the United States. The company develops medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers.